Perceptive Advisors LLC Xenon Pharmaceuticals Inc. Transaction History

Perceptive Advisors LLC

$3.83 Billion
Q3 2024

A detailed history of Perceptive Advisors LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 524,930 shares of XENE stock, worth $20.1 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

524,930

Previous 583,256 10.0%

Holding current value

$20.1 Million

Previous $22.7 Million 9.17%

% of portfolio

0.54%

Previous 0.66%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.12 - $43.96 $2.11 Million - $2.56 Million	-58,326 Reduced 10.0%	524,930 $20.7 Million
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $11.2 Million - $13.5 Million	-308,952 Reduced 34.63%	583,256 $22.7 Million
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $8.9 Million - $10.4 Million	-208,540 Reduced 18.95%	892,208 $38.4 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $13.9 Million - $22.5 Million	483,248 Added 78.26%	1,100,748 $50.7 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $20.7 Million - $24.1 Million	-605,877 Reduced 49.52%	617,500 $21.1 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $21.2 Million - $26.5 Million	-608,797 Reduced 33.23%	1,223,377 $47.1 Million
Q1 2023 May 15, 2023	SELL	$33.46 - $40.35 $2.98 Million - $3.6 Million	-89,099 Reduced 4.64%	1,832,174 $65.6 Million
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $6.65 Million - $7.94 Million	-201,262 Reduced 9.48%	1,921,273 $75.8 Million
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $7.35 Million - $10.2 Million	-288,912 Reduced 11.98%	2,122,535 $64.6 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $6.07 Million - $13.8 Million	389,396 Added 19.26%	2,411,447 $75.3 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $5.1 Million - $6.67 Million	343,078 Added 20.43%	2,022,051 $30.9 Million
Q2 2021 Aug 16, 2021	BUY	$16.81 - $20.0 $19.6 Million - $23.3 Million	1,163,931 Added 225.99%	1,678,973 $31.3 Million
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $7.03 Million - $11 Million	515,042 New	515,042 $9.22 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Xenon Pharmaceuticals Inc. Transaction History